News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Viktor Grunwald: Real-world cabozantinib after ICI
Photo from Viktor Grunwald/X
Sep 14, 2024, 13:51

Viktor Grunwald: Real-world cabozantinib after ICI

Viktor Grunwald, Professor of Interdisciplinary Genitourinary (GU) Oncology at the University Hospital Essen, shared a post on X, about paper published in Clinical Genitourinary Cancer:

Final Analysis of a Noninterventional Study on Cabozantinib in Patients With Advanced Renal Cell Carcinoma After Prior Checkpoint Inhibitor Therapy of the German Interdisciplinary Working Group on Renal Tumors (IAG-N).

Authors: Grünwald Viktor, Bögemann Martin, Rafiyan Mohammad-Reza, Niegisch Günter, Schnabel Marco, Flörcken Anne, Maasberg Michael, Maintz Christoph, Zahn Mark-Oliver, Wortmann Anke, Hinkel Andreas, Casper Jochen, Darr C, Hilser Thomas, Schulze M, Sookthai Disorn, Ivanyi Philipp.

Viktor Grunwald: Real-world cabozantinib after ICI

”Real-world cabozantinib after ICI:

  • Similar efficacy (shorter OS) compared to METEOR. 
  • 62% had lower starting doses (<60mg).
  • Similar outcome in low vs. 60 mg starting dose.
  • Less toxicity with lower dose.
  • Let’s re-think cabozantinib dosing.”

Source: Viktor Grunwald/X

Bögemann Martin Cabozantinib cancer Casper Jochen Clinical Genitourinary Cancer Darr C Flörcken Anne Grünwald Viktor Hilser Thomas Hinkel Andreas Ivanyi Philipp Maasberg Michael Maintz Christoph Niegisch Günter OncoDaily Oncology Rafiyan Mohammad-Reza Schnabel Marco Schulze M Sookthai Disorn University Hospital Essen Viktor Grünwald Wortmann Anke Zahn Mark-Oliver
Special Coverage
Science
Dec 29, 2024, 00:50
A must-read for people interested in late-line colorectal cancer treatments
Blog
Dec 28, 2024, 18:50
Roupen Odabashian: Creating and customizing templates for your specific needs with AI scribes
Blog
Dec 28, 2024, 18:47
Aruah Simeon Chinedu: Celebrating Runcie Chidebe, CEO of Project Pink Blue
Blog
Dec 28, 2024, 18:43
Emad Shash: Welcoming students from French International Schools in Egypt
Blog
Dec 28, 2024, 18:21
Shubh Goel: Grateful for all 2024 Has Delivered!
Blog
Dec 28, 2024, 18:21
Ngozi Cadmus: The body remembers what society denies.
Blog
Dec 28, 2024, 18:19
Harvey Castro: AI's Defining Year - 2024 in Review and A Glimpse into 2025
Blog
Dec 28, 2024, 18:19
Cynthia Jordan: A platform that would give people the information and conversations about their breast health
Blog
Dec 28, 2024, 18:19
The recipients of the IU Simon Comprehensive Cancer Center’s Merilyn Hester Scholarships
Blog
Dec 28, 2024, 18:19
Monica Bertagnolli: I recently welcomed Secretary of the Interior Deb Haaland to NIH
Blog
Dec 28, 2024, 18:19
Jasmine Kamboj: Parenthood challenges of IMG physicians in the U.S.
Blog
Dec 28, 2024, 18:19
Explore the 2025 AACI membership benefits and see how AACI enhances the impact of academic cancer centers